NCT06057012 - A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 29, 2023

Primary Completion Date

March 13, 2024

Study Completion Date

March 13, 2024

Conditions

Severe Postpartum Depression

Interventions

DRUG

BRII-296

BRII-296 will be given via intramuscular injection.

DRUG

Depo Medrol

Depo Medrol will be given via intramuscular injection.

Trial Locations (11)

Research Carolina Elite, Denver

iResearch Atlanta, LLC, Decatur

Synexus Clinical Research US, Inc., Atlanta

Cenexel ACMR Atlanta Center for Medical Research, Atlanta

South Florida Research Phase I-IV Inc, Miami Springs

Aventura Clinical Research, LLC, Davie

Clinical Research Center of Florida, Boynton Beach

North Texas Clinical Trials, Fort Worth

Maximos OB/GYN, League City

CenExel CNS-Torrance, Torrance

Cenexel CNR, Sherman Oaks